1-6 of 6
Kathryn Johnson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 study of canakinumab in patient with myelofibrosis: Results from part 1

Free
Andrew Kuykendall, Rupali Roy, Abdulraheem Yacoub, Marina Kremyanskaya, Aaron Gerds, Ronald Paquette, Jeanne Palmer, Kathryn Johnson, Heidi Kosiorek, Amylou Dueck, Carolyn Mead-Harvey, Ashley Yu, Rami Komrokji, Raajit Rampal, Ruben Mesa, Ronald Hoffman, John Mascarenhas
Journal: Blood
Blood (2025) 146 (Supplement 1): 483.
https://doi.org/10.1182/blood-2025-483
Published: 2025
Journal Articles

Phase II study of reparixin in patients with myelofibrosis. myeloproliferative neoplasms research consortium (MPN-RC) 120 trial

Free
Marina Kremyanskaya, Aaron Gerds, Rupali Bhave, Andrew Kuykendall, Eunice Wang, Heidi Kosiorek, Amylou Dueck, Carolyn Mead-Harvey, Kathryn Johnson, Ashley Yu, Anna Rita Migliaccio, Ruben Mesa, Ronald Hoffman, John Mascarenhas
Journal: Blood
Blood (2025) 146 (Supplement 1): 3829.
https://doi.org/10.1182/blood-2025-3829
Published: 2025
Journal Articles

Chemotherapy-Sparing Induction Followed By Consolidation and Maintenance with Blinatumomab and Concurrent Oral Tyrosine Kinase Inhibitor Therapy for Newly-Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Primary Endpoint Results from the Blissphall Study

Free
Mark Blaine Geyer, John Mascarenhas, Marissa Smith, Shakira Pascual, Anmol Shah, Michael R. Silvestrone, Tina Czaplinska, Kathryn Johnson, Meghan C. Thompson, Jae H. Park
Journal: Blood
Blood (2023) 142 (Supplement 1): 1510.
https://doi.org/10.1182/blood-2023-173551
Published: 2023
Journal Articles

Molecularly Targeted Combination Therapy for Advanced Phase Myeloproliferative Neoplasm: MPN-RC 119

Free
Michal Bar-Natan, John Mascarenhas, Aaron T. Gerds, Ruben Mesa, Vikas Gupta, Marina Kremyanskaya, Mikaela Dougherty, Frank Fabris, Kathryn Johnson, Ashley Yu, Heidi E. Kosiorek, Carolyn Mead-Harvey, Amylou C. Dueck, Ronald Hoffman, Raajit K Rampal
Journal: Blood
Blood (2022) 140 (Supplement 1): 3988–3990.
https://doi.org/10.1182/blood-2022-164678
Published: 2022
Journal Articles

Treatment of Myelofibrosis Patients with the TGF-β 1/3 Inhibitor AVID200 (MPN-RC 118) Induces a Profound Effect on Platelet Production

Free
John Mascarenhas, Heidi E. Kosiorek, Rupali Bhave, Jeanne M. Palmer, Andrew T. Kuykendall, Ruben A. Mesa, Raajit Rampal, Aaron T. Gerds, Abdulraheem Yacoub, Kristen M. Pettit, Moshe Talpaz, Rami S. Komrokji, Marina Kremyanskaya, Agapito Gonzalez, Frank Fabris, Lonette Sandy, Kathryn Johnson, Mikaela Doughtery, Erin McGovern, Juan Arango Ossa, Dylan Domenico, Noushin Farnoud, Anna Rita Migliaccio, Mohamed E Salama, Rona Singer Weinberg, Amy Kong, Vesna Najfeld, Carolyn Mead-Harvey, Amylou C. Dueck, Lilian Varricchio, Ronald Hoffman
Journal: Blood
Blood (2021) 138 (Supplement 1): 142.
https://doi.org/10.1182/blood-2021-148995
Published: 2021
Journal Articles

Results of a Phase II Study of PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

Free
Gabriela S. Hobbs, MD, Cansu Cimen Bozkus, Martha Wadleigh, MD, Lonette Sandy, Mikaela Doughtery, Kathryn Johnson, Gillian Sanchez, Julia E. Foster, NP, Molly Macrae, Tina T. Som, RN, Michal Bar-Natan, MD, Richard M. Stone, MD, Erin Moshier, MS, Camelia Iancu-Rubin, PhD, John Mascarenhas, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-137294
Published: 2020